Gemfibrozil (Page 5 of 5)
DOSAGE AND ADMINISTRATION
The recommended dose for adults is 1,200 mg administered in two divided doses 30 minutes before the morning and evening meals (see CLINICAL PHARMACOLOGY).
OVERDOSAGE
There have been reported cases of overdosage with gemfibrozil. In one case, a 7-year-old child recovered after ingesting up to 9 grams of gemfibrozil. Symptoms reported with overdosage were abdominal cramps, abnormal liver function tests, diarrhea, increased CPK, joint and muscle pain, nausea and vomiting. Symptomatic supportive measures should be taken, should an overdose occur.
HOW SUPPLIED
Gemfibrozil Tablets, USP
Supplied as White film-coated, capsule shaped, biconvex tablets de-bossed with I on the left side of bisect and G on the right side of bisect on one side and 225 on the other.
NDC 70934-255-30: Bottles of 30
NDC 70934-255-60: Bottles of 60
NDC 70934-255-90: Bottles of 90
Store at controlled room temperature 20° — 25°C (68° — 77°F) [see USP]. Protect from light and humidity. Preserve in tight containers.
Manufactured by:
InvaGen Pharmaceuticals, Inc.
(a subsidiary of Cipla Ltd.)
Hauppauge, NY 11788
Manufactured for:
Cipla USA, Inc.
10 Independence Boulevard, Suite 300
Warren, NJ 07059
Revised:01/2021
To report SUSPECTED ADVERSE REACTIONS, contact Cipla Ltd. at 1-866-604-3268 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC: 70934-255-30
GEMFIBROZIL gemfibrozil tablet | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
|
Labeler — Denton Pharma, Inc. DBA Northwind Pharmaceuticals (080355546) |
Registrant — Denton Pharma, Inc. DBA Northwind Pharmaceuticals (080355546) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 080355546 | repack (70934-255) |
Revised: 01/2023 Denton Pharma, Inc. DBA Northwind Pharmaceuticals
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.